1. Home
  2. SRPT vs GNL Comparison

SRPT vs GNL Comparison

Compare SRPT & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • GNL
  • Stock Information
  • Founded
  • SRPT 1980
  • GNL 2011
  • Country
  • SRPT United States
  • GNL United States
  • Employees
  • SRPT N/A
  • GNL N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • GNL Real Estate Investment Trusts
  • Sector
  • SRPT Health Care
  • GNL Real Estate
  • Exchange
  • SRPT Nasdaq
  • GNL Nasdaq
  • Market Cap
  • SRPT 1.7B
  • GNL 1.6B
  • IPO Year
  • SRPT 1997
  • GNL N/A
  • Fundamental
  • Price
  • SRPT $21.70
  • GNL $7.51
  • Analyst Decision
  • SRPT Hold
  • GNL Buy
  • Analyst Count
  • SRPT 29
  • GNL 3
  • Target Price
  • SRPT $46.15
  • GNL $9.00
  • AVG Volume (30 Days)
  • SRPT 22.8M
  • GNL 1.8M
  • Earning Date
  • SRPT 08-06-2025
  • GNL 08-06-2025
  • Dividend Yield
  • SRPT N/A
  • GNL 10.05%
  • EPS Growth
  • SRPT N/A
  • GNL N/A
  • EPS
  • SRPT N/A
  • GNL N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • GNL $768,986,000.00
  • Revenue This Year
  • SRPT $3.52
  • GNL N/A
  • Revenue Next Year
  • SRPT N/A
  • GNL N/A
  • P/E Ratio
  • SRPT N/A
  • GNL N/A
  • Revenue Growth
  • SRPT 64.89
  • GNL 24.38
  • 52 Week Low
  • SRPT $10.42
  • GNL $6.51
  • 52 Week High
  • SRPT $144.22
  • GNL $9.11
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 57.32
  • GNL 56.94
  • Support Level
  • SRPT $17.28
  • GNL $7.39
  • Resistance Level
  • SRPT $20.61
  • GNL $7.70
  • Average True Range (ATR)
  • SRPT 1.51
  • GNL 0.20
  • MACD
  • SRPT 0.96
  • GNL 0.08
  • Stochastic Oscillator
  • SRPT 95.91
  • GNL 79.38

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: